Tissue prices are an essential part of private handicapping. They are our own fair odds line — an estimate of each runner’s chance expressed as a betting price, built from form analysis, ratings, and profiling. With the TimeWise method, these estimates emerge from a structured process based on Timeform adjusted ratings, race dynamics, pace and draw, trainer patterns, market signals, and trends.

The foundation is always the private handicap figure — a weight-adjusted rating refined through subjective and objective lenses. From there, horses are grouped by lbs difference from the top-rated. This grouping helps estimate how many runners belong in the ‘Dangers’, ‘Possible Place’, or ‘No Chance’ zones. We assign rough win probabilities to each band based on historical conversion rates (e.g., each 3–4lb difference often correlates with a 1.5x odds multiple).

Then, the favourite’s likely fair price (e.g. 9/4 if there are only two within 3lbs) is used as an anchor, with others worked out from their groupings using the lbs-based differential model.

The more data we feed into the process — such as trainer strike rates, horse fitness, pace setup, and historical trends — the more accurately we can refine these prices. For example, if a horse is off 200 days but comes from a yard with a strong fresh record, the layoff penalty might be reduced. Conversely, a horse downgraded on pace unsuitability can justifiably be lengthened. Timeform’s Smart Stats, adjusted figures, and profile flags help add confidence or caution to these ratings. This layered approach guards against overrating hype or underrating unfashionable yards.

Ultimately, the goal isn’t to ‘guess the market’ — it’s to estimate a horse’s actual win chance. And the more comprehensive the input, the better the estimate.

What Is a Good Bet?

A good bet arises when the market price is significantly larger than our tissue price, and we’re confident in the strength of our analysis. This is the core of value betting: we are not simply backing what we think will win, but what is overpriced relative to its true chance.

For example, if we make a horse 3/1 (25% chance) on our tissue, but the market has it at 6/1 (14.3%), and our inputs are solid, that’s a clear value play — regardless of whether it wins or not.

The key is repeating this process with consistency over time, avoiding emotion or guesswork, and trusting the model.

---

How We Use Tissue Odds in Common Scenarios

1. Unexposed Horses

• These are naturally trickier to assess, so our tissue prices should reflect that uncertainty.
• However, if we spot strong signals — such as positive trainer stats, smart debut efforts, or promising pedigree patterns — we may still find value.
• We tend to price these types with wider ranges unless there’s supporting evidence from the stable’s track record or the horse’s profile.

2. Exposed Horses in Form with Suitable Conditions

• These are often prominent in the betting — and the market usually has them about right.
• But if our tissue has one of these types shorter than the market — say, we make it 9/4 and it’s trading 4/1 — then that’s a solid angle. These are horses we can trust under known conditions.

3. Horses Returning from a Layoff

• We always factor in the layoff — particularly over 90 days — and apply a fitness penalty unless the trainer is known for getting them ready fresh.
• If the market is short on a horse and our tissue says it should be longer based on fitness risk, we’re happy to oppose.
• But equally, if we’ve factored in the layoff and still rate it strongly, and the market doesn’t — that gives us a value opportunity.

4. Young Horses vs Older Ones

• In handicaps, unexposed 3- or 4-year-olds often bring improvement potential, especially when stepping into their first or second handicap.
• But we don’t assume progress — we look for profile clues, trainer intent, and race set-up before shortening them on our tissue.
• When conditions align and the opposition is exposed, these younger horses may be underbet relative to our private line.

5. Going Changes

• We always recheck our figures if there’s a significant going change — especially if it goes soft or firm unexpectedly.
• Horses with proven ability in the new ground conditions are upgraded slightly, while those with clear doubts or poor records are eased out.
• This is where Timeform profiles and pedigree notes become especially useful in reinforcing our pricing logic.

6. Strong Headwinds or Notable Pace Bias

• In races affected by a headwind — particularly sprints — front-runners or wide-drawn leaders may be downgraded in our tissue.
• If we expect a pace collapse or a race to set up for closers, we reflect that in how we group and price each runner.
• When the pace map suggests tactical uncertainty, we’re quick to adjust prices for horses likely to be at a positional disadvantage.

---

Final Guidelines for Using Tissue Prices Effectively

• Confidence is key. The more well-founded our ratings, pace read, and profiling, the more confident we can be that our tissue is reliable.
• Discipline is vital. We don’t bet unless the market offers a bigger price than our fair odds — and we’re happy to pass races when no value appears.
• We avoid chasing steam. If a runner is being overhyped and we’ve rated it lower for good reason, we stick to our guns.
• We review value clusters. When multiple horses are overpriced relative to our figures, especially in open races with a weak favourite, we may back more than one (win/place or dutch).

---

In summary, our tissue prices are not predictions — they’re measured estimates of each runner’s actual chance. A good bet is one where the public market underestimates a horse compared to our model — and the more rigorous and informed our inputs, the more profitably we can act on those opportunities.